Tecrea Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Tecrea General Information
Description
Developer of a nanotechnology platform designed to provide a unique range of cell and tissue delivery tools that are fully translatable from the lab to the clinic. The company develops reagent tools that offer enormous potential for advances in drug efficiency and targeted delivery, and offers expertise in the field of molecular medicine research and development with Nanocin transfection reagents, enabling biomedical researchers and therapeutic developers to achieve precise, rapid, and scalable delivery of genetic and molecular payloads with minimal cytotoxicity and high reproducibility across experimental and therapeutic workflows.
Contact Information
Website
www.tecrea.comCorporate Office
- London Bioscience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Corporate Office
- London Bioscience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Tecrea Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 19-Nov-2024 | Completed | Generating Revenue | |||
| 2. Grant | 02-Apr-2015 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 27-Feb-2012 | Completed | Generating Revenue |
Tecrea Patents
Tecrea Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202013773-D0 | Method of viral inactivation | Inactive | 02-Sep-2020 | ||
| GB-201306980-D0 | Methods | Inactive | 17-Apr-2013 | ||
| CA-2850145-A1 | Guanides as cell entry promoting agents | Active | 11-Oct-2011 | ||
| CA-2850145-C | Guanides as cell entry promoting agents | Active | 11-Oct-2011 | ||
| AU-2012322441-A1 | Methods | Active | 11-Oct-2011 | A61K31/713 |
Tecrea Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tecrea Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelerating FemTech | Accelerator/Incubator | |||
| Innovate UK | Government | Minority | ||
| Royal Veterinary College | University |
Tecrea Investments (1)
Tecrea’s most recent deal was a Grant with Tozaro for . The deal was made on 19-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tozaro | 19-Sep-2025 | Grant | Discovery Tools (Healthcare) |
Tecrea FAQs
-
When was Tecrea founded?
Tecrea was founded in 2012.
-
Where is Tecrea headquartered?
Tecrea is headquartered in London, United Kingdom.
-
What is the size of Tecrea?
Tecrea has 6 total employees.
-
What industry is Tecrea in?
Tecrea’s primary industry is Discovery Tools (Healthcare).
-
Is Tecrea a private or public company?
Tecrea is a Private company.
-
What is Tecrea’s current revenue?
The current revenue for Tecrea is .
-
Who are Tecrea’s investors?
Accelerating FemTech, Innovate UK, and Royal Veterinary College have invested in Tecrea.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
